Pharmascience PMS-Losartan product recall (2021-10-13) Oct 13, 2021 · Published by Health Canada · Official notice
Share
Alert type : Drug Recall
Category : Drugs
Issue : Product Safety
Audience : General Public, Healthcare Professionals, Hospitals
Department : Health Canada
Hazard classification : Type I
A. PMS-Losartan 25mg
Lot or serial number Companies Brand name DIN, NPN, DIN-HIM Dosage form Strength 629302, 636348, 636357 Recalling Firm Pharmascience Inc. 6111 Royalmount Avenue Montreal H4P 2T4 CANADA Marketing Authorization Holder Pharmascience Inc. 6111 Royalmount Avenue Montreal H4P 2T4 CANADA B. PMS-Losartan 50mg DIN 02309769 Tablet Losartan Potassium 50mg 629306, 629307,636346,636358 Recalling Firm Pharmascience Inc. 6111 Royalmount Avenue Montreal H4P 2T4 CANADA Marketing Authorization Holder Pharmascience Inc. 6111 Royalmount Avenue Montreal H4P 2T4 CANADA C. PMS-Losartan 100mg DIN 02309777 Tablet Losartan Potassium 100mg 629303, 636356 Recalling Firm Pharmascience Inc. 6111 Royalmount Avenue Montreal H4P 2T4 CANADA Marketing Authorization Holder Pharmascience Inc. 6111 Royalmount Avenue Montreal H4P 2T4 CANADA A. PMS-Losartan 25mg DIN 02309750 Tablet Losartan Potassium 25mg
A. PMS-Losartan 25mg
B. PMS-Losartan 50mg
C. PMS-Losartan 100mg
Presence of impurity (5-[4'-[(5-(Azidomethyl)-2-butyl-4-chloro-1H-imidazol-1-yl)methyl]-[1,1'-biphenyl]-2-yl]-1H-tetrazole) above the acceptable concentration limit in affected lots